MICRONISED PROGESTERONE
Micronised Progesterone is a form of progesterone that is processed to enhance absorption and bioavailability. It is commonly used in hormone replacement therapy and to support various gynecological conditions.-Hormone replacement therapy in menopausal women -Treatment of irregular menstrual cycles -Management of endometriosis -Support in fertility treatments -Prevention of preterm birth in women with a history of preterm labor
-For Hormone Replacement Therapy: Typically 200-400 mg daily, administered orally. -For Endometriosis: 100-200 mg daily. -For Fertility Treatments: Dosage varies based on the protocol and individual needs.
Known hypersensitivity to progesterone or any component of the formulation -Active or history of thromboembolic disorders -Severe liver disease -Undiagnosed vaginal bleeding
-Use with caution in patients with a history of cardiovascular disease, diabetes, or liver disorders. -Regular monitoring of blood pressure and glucose levels may be necessary. -May cause drowsiness or dizziness; caution is advised when driving or operating machinery.
-Common: Headache, nausea, breast tenderness, mood changes. -Less common: Weight gain, acne, dizziness, fatigue. -Rare but serious: Thromboembolic events, liver dysfunction, severe allergic reactions.
-May interact with anticoagulants, antiepileptics, and certain antibiotics. -Possible interactions with other hormone therapies or oral contraceptives. -Consult with a healthcare provider before combining with other medications.
